Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ravindra P Veeranna

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Venues

Vaccines

Pathogens (Basel, Switzerland)

Cells

PLoS pathogens

CSIR-Central Food Technological Research Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CSIR-Central Food Technological Research Institute Oct 30o 2014

India

Principal Investigator :: Biochemistry

Publications

Siva Dallavalasa, SubbaRao V Tulimilli, Janhavi Prakash, Ramya Ramachandra, SubbaRao V Madhunapantula, Ravindra P Veeranna
COVID-19: Diabetes Perspective-Pathophysiology and Management. Pathogens (Basel, Switzerland) 12 (2) (2023)
Saiswaroop R, Akhil P Soman, Kanikaram Sai Phalguna, Sai Sanwid Pradhan, Meghana Manjunath, Raksha Kanthavara Rao, Rajesh Babu Dandamudi, Sai Krishna Srimadh Bhagavatham, Sujith Kumar Pulukool, Sriram Rathnakumar, Sai Kocherlakota, Ashish Pargaonkar, Ravindra P Veeranna, Natarajan Arumugam, Abdulrahman I Almansour, Bibha Choudhary, Venketesh Sivaramakrishnan
Integrated Omic Analysis Delineates Pathways Modulating Toxic TDP-43 Protein Aggregates in Amyotrophic Lateral Sclerosis. Cells 12 (9) (2023)
Siva Dallavalasa, SubbaRao V Tulimilli, Janhavi Prakash, Ramya Ramachandra, SubbaRao V Madhunapantula, Ravindra P Veeranna
COVID-19: Diabetes Perspective-Pathophysiology and Management. Pathogens (Basel, Switzerland) 12 (2) (2023)
Saiswaroop R, Akhil P Soman, Kanikaram Sai Phalguna, Sai Sanwid Pradhan, Meghana Manjunath, Raksha Kanthavara Rao, Rajesh Babu Dandamudi, Sai Krishna Srimadh Bhagavatham, Sujith Kumar Pulukool, Sriram Rathnakumar, Sai Kocherlakota, Ashish Pargaonkar, Ravindra P Veeranna, Natarajan Arumugam, Abdulrahman I Almansour, Bibha Choudhary, Venketesh Sivaramakrishnan
Integrated Omic Analysis Delineates Pathways Modulating Toxic TDP-43 Protein Aggregates in Amyotrophic Lateral Sclerosis. Cells 12 (9) (2023)
Siva Dallavalasa, SubbaRao V Tulimilli, Janhavi Prakash, Ramya Ramachandra, SubbaRao V Madhunapantula, Ravindra P Veeranna
COVID-19: Diabetes Perspective-Pathophysiology and Management. Pathogens (Basel, Switzerland) 12 (2) (2023)
Siva Dallavalasa, SubbaRao V Tulimilli, Janhavi Prakash, Ramya Ramachandra, SubbaRao V Madhunapantula, Ravindra P Veeranna
COVID-19: Diabetes Perspective-Pathophysiology and Management. Pathogens (Basel, Switzerland) 12 (2) (2023)
Saiswaroop R, Akhil P Soman, Kanikaram Sai Phalguna, Sai Sanwid Pradhan, Meghana Manjunath, Raksha Kanthavara Rao, Rajesh Babu Dandamudi, Sai Krishna Srimadh Bhagavatham, Sujith Kumar Pulukool, Sriram Rathnakumar, Sai Kocherlakota, Ashish Pargaonkar, Ravindra P Veeranna, Natarajan Arumugam, Abdulrahman I Almansour, Bibha Choudhary, Venketesh Sivaramakrishnan
Integrated Omic Analysis Delineates Pathways Modulating Toxic TDP-43 Protein Aggregates in Amyotrophic Lateral Sclerosis. Cells 12 (9) (2023)
Ganesh Korishettar, Prashanth Chikkahonnaiah, SubbaRao V Tulimilli, Siva Dallavalasa, Shashidhar H Byrappa, SubbaRao V Madhunapantula, Ravindra P Veeranna
Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients. Vaccines 10 (7) (2022)
Purvita Chowdhury, Shinjini Bhattacharya, Bhaskarjyoti Gogoi, Ravindra P Veeranna, Sachin Kumar
An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination. Vaccines 10 (10) (2022)
SubbaRao V Tulimilli, Siva Dallavalasa, Chaithanya G Basavaraju, Vinay Kumar Rao, Prashanth Chikkahonnaiah, SubbaRao V Madhunapantula, Ravindra P Veeranna
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness. Vaccines 10 (10) (2022)
Santhinissi Addala, Madhuri Vissapragada, Madhumita Aggunna, Niharikha Mukala, Manisha Lanka, Shyamkumar Gampa, Manikanta Sodasani, Jahnavi Chintalapati, Akhila Kamidi, Ravindra P Veeranna, Ravikiran S Yedidi
Success of Current COVID-19 Vaccine Strategies vs. the Epitope Topology of SARS-CoV-2 Spike Protein-Receptor Binding Domain (RBD): A Computational Study of RBD Topology to Guide Future Vaccine Design. Vaccines 10 (6) (2022)
Prabha Shrestha, David A Davis, Ravindra P Veeranna, Robert F Carey, Coralie Viollet, Robert Yarchoan
Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma. PLoS pathogens 13 (9) (2017)

Ravindra P Veeranna.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ravindra P Veeranna